InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Phone+1-248-2911210
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date4/23/2019 (Estimated)
OptionableNot Optionable
InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions
What is InfuSystem's stock symbol?
InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."
How will InfuSystem's stock buyback program work?
InfuSystem announced that its board has approved a stock buyback program on Tuesday, March 13th 2018, which permits the company to repurchase 1,000,000 shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board believes its shares are undervalued.
How were InfuSystem's earnings last quarter?
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) issued its quarterly earnings results on Thursday, March, 7th. The medical instruments supplier reported ($0.01) earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $17.56 million for the quarter. View InfuSystem's Earnings History.
When is InfuSystem's next earnings date?
Has InfuSystem been receiving favorable news coverage?
Media coverage about INFU stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. InfuSystem earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the next few days.
Who are some of InfuSystem's key competitors?
Some companies that are related to InfuSystem include Clover (CLV), CRH Medical (CRH), Bovie Medical (BVX), Bovie Medical (BVX), CRH Medical (CRHM), Tristel (TSTL), SDI (SDI), Daxor (DXR), TSO3 (TOS), IsoRay (ISR), IsoRay (ISR), Retractable Technologies (RVP), Omega Diagnostics Group (ODX), Milestone Scientific (MLSS) and Impression Healthcare (IHL).
What other stocks do shareholders of InfuSystem own?
Who are InfuSystem's key executives?
InfuSystem's management team includes the folowing people:
- Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
- Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
- Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
- Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
- Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives
Who are InfuSystem's major shareholders?
InfuSystem's stock is owned by a number of of retail and institutional investors. Top institutional investors include White Pine Capital LLC (1.62%), Dimensional Fund Advisors LP (1.17%), Dimensional Fund Advisors LP (1.17%) and Price Wealth Management Inc. (1.02%). Company insiders that own InfuSystem stock include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, David C Dreyer, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Ryan J Morris, Scott Shuda and Terry L Armstrong. View Institutional Ownership Trends for InfuSystem.
Which major investors are selling InfuSystem stock?
Which major investors are buying InfuSystem stock?
INFU stock was purchased by a variety of institutional investors in the last quarter, including Price Wealth Management Inc., Dimensional Fund Advisors LP and Dimensional Fund Advisors LP. Company insiders that have bought InfuSystem stock in the last two years include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Ronald H Jr Peele, Ryan J Morris, Scott Shuda and Terry L Armstrong. View Insider Buying and Selling for InfuSystem.
How do I buy shares of InfuSystem?
Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InfuSystem's stock price today?
One share of INFU stock can currently be purchased for approximately $4.68.
How big of a company is InfuSystem?
InfuSystem has a market capitalization of $91.46 million.
What is InfuSystem's official website?
How can I contact InfuSystem?
InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.
MarketBeat Community Rating for InfuSystem (NYSEAMERICAN INFU)
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe INFU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days.
